High-tech mock-up unveiled for Queensland’s locally built train fleet

Queensland has taken a significant step forward in its train manufacturing program with the unveiling of a full-scale mock-up designed to test accessibility features for the state’s next generation of passenger trains. The 38-metre replica, built in Maryborough by Indigenous-owned business Allweld, replicates the train cab and two carriages of the future fleet. It will…

Details

Five misconceptions about manufacturing that belong in the past

By Madeleine North, Senior Writer, Forum Stories When we think about AI transforming industries, manufacturing is probably not the first one that springs to mind. And, yet, the sector is embracing the technology more rapidly than oil, gas and mining, government administration, and even healthcare. Misconceptions about manufacturing are not contained to tech, either. Here, four New Generation Industry…

Details

Australian engineers develop brain-like device for next-gen visual processing

RMIT University researchers have created a breakthrough “neuromorphic” device that can detect hand movements, store memories, and process information like a human brain—all without requiring an external computer. This tiny innovation, which mimics how our eyes capture light and our brains process visual information, represents a significant advancement toward enabling instant visual processing in autonomous…

Details

Livium secures expanded battery recycling deal with BYD Australia

Livium has signed a new expanded recycling agreement with BYD Australia, broadening its battery recycling scope to include commercial vehicle batteries and energy storage systems in addition to electric vehicle batteries, according to an ASX announcement released on Monday. The three-year agreement, which commenced on May 1, positions Livium’s subsidiary Envirostream Australia as BYD’s preferred…

Details

$1.25 million awarded to progress University of Queensland-developed prostate cancer drug

Development of a new drug based on research at The University of Queensland, targeting advanced and therapy-resistant prostate cancer, has been awarded $1.25 million from the US-based Critical Path Institute’s Translational Therapeutics Accelerator. According to a statement from UQ on Tuesday, the drug named QED-203 has its origins in research by Professor Greg Monteith from…

Details